paclitaxel has been researched along with Signet Ring Cell Carcinoma in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 14 (66.67) | 29.6817 |
| 2010's | 7 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Batran, SE; Alsina, M; Bang, YJ; Boku, N; Chung, HC; Conti, I; Evesque, L; Hallwachs, R; Hong, J; Lee, KW; Lichinitser, M; Moehler, MH; Park, SH; Ruiz, EY; Ryu, MH; Schenker, M; Taieb, J; Van Cutsem, E; Wyrwicz, L; Xiong, H | 1 |
| Chiba, Y; Imano, M; Iwama, M; Kimura, Y; Nishida, S; Shinkai, M; Shiraisi, O; Tsubaki, M; Yasuda, A; Yasuda, T | 1 |
| Cao, YC; Geng, M; Li, PF; Wang, L; Yin, YC | 1 |
| Goto, S; Kamigaki, T; Saito, M; Yano, K | 1 |
| Bu, Z; Fan, B; Ji, J; Li, S; Li, Z; Ren, H; Shan, F; Tang, L; Wu, A; Wu, X; Zhang, L; Zong, X | 1 |
| Li, J; Li, Y; Lu, M; Shen, L; Xiao, Y; Zhang, J; Zhang, XD | 1 |
| An, X; He, Y; Li, Y; Wang, F; Wang, Z; Xu, R; Zhou, N | 1 |
| Ge, FJ; Lin, L; Liu, LJ; Wang, Y; Xu, JM; Zhao, CH; Zhuang, QX | 1 |
| Ezaki, T; Ikegami, T; Ishida, T; Itoh, H; Kawaguchi, K; Kido, A; Nose, N; Sasaki, Y; Shimokawa, H | 1 |
| Ong, NC; Ostör, AG | 1 |
| Chida, N; Imai, G; Ishibashi, J; Iwabuchi, M; Matsuda, Y; Mochida, A; Shiina, M; Suzuki, S; Suzuki, T; Tadokoro, K; Takahashi, H; Yamada, K; Yokoyama, H | 1 |
| Ishikawa, T; Kamimura, T; Mizuno, K; Ohta, H; Seki, K; Togashi, T; Watanabe, K; Yoshida, T | 1 |
| Akanuma, M; Hata, Y; Kuriyama, H; Nonaka, T; Sawatari, T; Tsuboi, H | 1 |
| Chijiiwa, K; Eto, TA; Hotokezaka, M; Iwamura, T; Shibata, N | 1 |
| Fujimori, M; Fukuyama, Y; Hayasaka, A; Inkyo, T; Koma, Y; Nagashima, F; Ohbu, M; Saisho, H; Sakai, Y; Saotome, T; Sato, T; Shimizu, S; Tsuchiya, S; Tsuyuguchi, T; Yugeta, H | 1 |
| Fukasawa, T; Gotoh, H; Shoji, T; Taniwaka, K | 1 |
| Shimizu, S; Tsuchiya, K; Yasui, C | 1 |
| Aiba, T; Furukawa, K; Igarashi, K; Ikeda, H; Iwamoto, Y; Kuwabara, S; Shibuya, H; Shobugawa, K; Takizawa, K; Tsukioka, S; Waguri, N; Yabe, M; Yoneyama, O | 1 |
| Hayashi, N; Ishida, H; Kodama, T; Mori, K; Noguchi, M; Okamoto, R; Okino, T; Takahashi, H | 1 |
| Cho, H; Hasegawa, S; Kobayashi, O; Osaragi, T; Sairenji, M; Tsuburaya, A; Yoshida, T; Yoshikawa, T | 1 |
| Cao, YC; Fu, ZJ; Geng, M; Tai, YH; Wang, XY; Yin, YC | 1 |
1 review(s) available for paclitaxel and Signet Ring Cell Carcinoma
| Article | Year |
|---|---|
Atypical generalized granuloma annulare associated with two visceral cancers.
Topics: Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carboplatin; Carcinoma, Signet Ring Cell; Cystadenocarcinoma, Mucinous; Female; Granuloma Annulare; Humans; Ovarian Neoplasms; Paclitaxel; Stomach Neoplasms | 2006 |
3 trial(s) available for paclitaxel and Signet Ring Cell Carcinoma
| Article | Year |
|---|---|
Phase III, randomised trial of avelumab versus physician's choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Papillary; Carcinoma, Signet Ring Cell; Choice Behavior; Decision Support Techniques; Esophageal Neoplasms; Esophagogastric Junction; Female; Follow-Up Studies; Humans; International Agencies; Irinotecan; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Practice Patterns, Physicians'; Prognosis; Stomach Neoplasms; Survival Rate; Young Adult | 2018 |
Phase II trial of neoadjuvant chemotherapy with intraperitoneal paclitaxel, S-1, and intravenous cisplatin and paclitaxel for stage IIIA or IIIB gastric cancer.
Topics: Adenocarcinoma; Administration, Intravenous; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Chemotherapy, Adjuvant; Cisplatin; Drug Combinations; Feasibility Studies; Female; Follow-Up Studies; Humans; Injections, Intraperitoneal; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Oxonic Acid; Paclitaxel; Stomach Neoplasms; Survival Rate; Tegafur; Young Adult | 2019 |
Phase II study of biweekly paclitaxel plus infusional 5-fluorouracil and leucovorin as first-line chemotherapy in patients with advanced gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Female; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Peritoneal Neoplasms; Skin Neoplasms; Stomach Neoplasms; Survival Rate; Time Factors; Treatment Outcome | 2011 |
17 other study(ies) available for paclitaxel and Signet Ring Cell Carcinoma
| Article | Year |
|---|---|
Correlation between chemosensitivity to anticancer drugs and telomerase reverse transcriptase mRNA expression in gastric cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Antineoplastic Agents; Biomarkers, Tumor; Carcinoma, Signet Ring Cell; Case-Control Studies; Cell Differentiation; Cell Survival; Cisplatin; Doxorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Fluorouracil; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; In Situ Hybridization; Mitomycin; Neoplasm Grading; Paclitaxel; RNA, Messenger; Stomach Neoplasms; Telomerase; Tumor Cells, Cultured | 2013 |
A patient with scirrhous stomach cancer treated with combination of hyperthermotherapy and 5-aminolevulinic acid (ALA).
Topics: Adenocarcinoma, Scirrhous; Adult; Aminolevulinic Acid; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Signet Ring Cell; Cisplatin; Combined Modality Therapy; Dichloroacetic Acid; Docetaxel; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hyperthermia, Induced; Irinotecan; Ovarian Neoplasms; Oxonic Acid; Paclitaxel; Peritoneal Neoplasms; Photosensitizing Agents; Prognosis; Silicates; Stomach Neoplasms; Taxoids; Tegafur; Titanium | 2013 |
Gastrectomy in comprehensive treatment of advanced gastric cancer with synchronous liver metastasis: a prospectively comparative study.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma, Signet Ring Cell; Carcinoma, Small Cell; Case-Control Studies; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Follow-Up Studies; Gastrectomy; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Grading; Neoplasm Staging; Neoplasms, Multiple Primary; Paclitaxel; Prognosis; Prospective Studies; Stomach Neoplasms; Survival Rate | 2015 |
[Retrospective study on regimens of capecitabine-based chemotherapy in the treatment for advanced gastric cancer].
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma, Signet Ring Cell; Cisplatin; Deoxycytidine; Docetaxel; Female; Fluorouracil; Follow-Up Studies; Humans; Leukopenia; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Remission Induction; Retrospective Studies; Stomach Neoplasms; Survival Rate; Taxoids; Vomiting; Young Adult | 2009 |
[Clinical analysis of the current treatment status of gastric cancer in 636 patients].
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Chemotherapy, Adjuvant; China; Cisplatin; Disease-Free Survival; Female; Gastrectomy; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Retrospective Studies; Salvage Therapy; Stomach Neoplasms; Survival Rate; Trastuzumab; Young Adult | 2012 |
[Effective weekly paclitaxel administration for gastric cancer with malignant ascites--a case report].
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Ascites; Carcinoma, Signet Ring Cell; Drug Administration Schedule; Female; Fluorouracil; Humans; Leucovorin; Middle Aged; Paclitaxel; Stomach Neoplasms; Treatment Outcome | 2002 |
Borderline mucinous tumour with mural nodule of signet ring adenocarcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Signet Ring Cell; Combined Modality Therapy; Cystadenocarcinoma, Mucinous; Female; Gynecologic Surgical Procedures; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Paclitaxel | 2002 |
[Treatment outcomes with paclitaxel for advanced gastric cancer patients previously treated with TS-1].
Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Cisplatin; Drug Administration Schedule; Drug Combinations; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Oxonic Acid; Paclitaxel; Pyridines; Remission Induction; Stomach Neoplasms; Tegafur; Treatment Outcome | 2003 |
[A case of advanced gastric cancer with bone metastasis and severe DIC responding to hypertensive subselective chemotherapy with pharmacokinetic modulating chemotherapy].
Topics: Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Signet Ring Cell; Disseminated Intravascular Coagulation; Drug Administration Schedule; Drug Combinations; Female; Fluorouracil; Humans; Infusion Pumps, Implantable; Methotrexate; Middle Aged; Paclitaxel; Quality of Life; Stomach Neoplasms; Tegafur; Uracil | 2005 |
[A case of advanced gastric cancer with peritoneal dissemination effectively treated by combined chemotherapy of paclitaxel (TXL) and TS-1].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Drug Administration Schedule; Drug Combinations; Female; Humans; Middle Aged; Oxonic Acid; Paclitaxel; Peritoneal Neoplasms; Pyridines; Quality of Life; Stomach Neoplasms; Tegafur | 2005 |
[An unresectable advanced gastric cancer with Virchow's metastasis, carcinomatous ascites and rectal stenosis, effectively managed with combined chemotherapy of biweekly paclitaxel and TS-1].
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Ascites; Carcinoma, Signet Ring Cell; Constriction, Pathologic; Drug Administration Schedule; Drug Combinations; Female; Humans; Lymphatic Metastasis; Oxonic Acid; Paclitaxel; Peritonitis; Pyridines; Rectal Diseases; Stomach Neoplasms; Tegafur | 2005 |
[A pilot study of TS-1+CDDP therapy for highly advanced stage IV gastric cancer].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Drug Combinations; Female; Humans; Male; Middle Aged; Oxonic Acid; Paclitaxel; Pilot Projects; Pyridines; Quality of Life; Stomach Neoplasms; Tegafur | 2005 |
[A long-term survivor with stage IV gastric cancer due to postoperative weekly paclitaxel and 5'-DFUR combination therapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Combined Modality Therapy; Drug Administration Schedule; Female; Floxuridine; Gastrectomy; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Paclitaxel; Quality of Life; Salvage Therapy; Stomach Neoplasms; Survivors | 2006 |
[A case of gastric cancer with abdominal wall invasion treated by weekly low-dose paclitaxel therapy].
Topics: Abdominal Wall; Adenocarcinoma; Antineoplastic Agents, Phytogenic; Carcinoma, Signet Ring Cell; Drug Administration Schedule; Humans; Male; Middle Aged; Neoplasm Invasiveness; Paclitaxel; Radiography, Abdominal; Stomach Neoplasms; Tomography, X-Ray Computed | 2006 |
[A case report of complete response by TS-1 and paclitaxel combination chemotherapy for advanced gastric cancer].
Topics: Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Drug Administration Schedule; Drug Combinations; Female; Humans; Middle Aged; Ovarian Neoplasms; Oxonic Acid; Paclitaxel; Quality of Life; Remission Induction; Stomach Neoplasms; Tegafur | 2006 |
[A case of breast metastasis of gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Signet Ring Cell; Cisplatin; Drug Combinations; Female; Gastrectomy; Humans; Lymphatic Metastasis; Middle Aged; Neoplastic Cells, Circulating; Oxonic Acid; Paclitaxel; Stomach Neoplasms; Tegafur; Uracil | 2007 |
[Anti-tumor effects of chemotherapeutic drugs on human gastric cancer cells in vitro and the relationship with expression of hTERT mRNA].
Topics: Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carcinoma, Signet Ring Cell; Cell Proliferation; Cisplatin; Doxorubicin; Drug Resistance, Neoplasm; Female; Fluorouracil; Humans; Male; Middle Aged; Mitomycin; Paclitaxel; RNA, Messenger; Stomach Neoplasms; Telomerase | 2007 |